Skip to main content

Save up to 20% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 20% on print and eBooks.

Characterization of Micro and Nanoparticles for Biomedical Applications

1st Edition - September 1, 2024

Editors: Ranjita Shegokar, Eliana B. Souto

Language: English
Paperback ISBN:
9 7 8 - 0 - 3 2 3 - 9 6 1 3 8 - 7
eBook ISBN:
9 7 8 - 0 - 3 2 3 - 9 6 1 3 9 - 4

Characterization of Micro and Nanoparticles for Biomedical Applications is a helpful guide for industry researchers, academicians, regulatory experts and material scientist… Read more

Characterization of Micro and Nanoparticles for Biomedical Applications

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Characterization of Micro and Nanoparticles for Biomedical Applications is a helpful guide for industry researchers, academicians, regulatory experts and material scientists working in the field of pharmaceuticals, cosmeceuticals, nutraceuticals, agriculture, food, fragrance, and in the chemical industries. It aims to provide a one-stop resources on all the analytical techniques used in the field of micro and nanoparticles evaluation and characterization. The book's chapters bring together knowledge on current analytical methodologies, limitations and advances in the in vitro analysis field.

Users from the equipment industry will benefit from its innovations by understanding the needs of researchers and the challenges of current techniques. With the expectation of "high-quality data" essentially dependent on the analytical methodology applied for characterization, this is integral to success. For routine products like tablets, capsules, and solutions, the regulatory guidelines, product-specific monographs, and pharmacopoeial annexures are set and "standard of operation." However, for nano-micro pharmaceuticals, regulatory guidelines are still evolving.